Optimizing cancer immunotherapy trials: back to basics. (Q53625750)

16 May 2018

title

Optimizing cancer immunotherapy trials: back to basics. (English)

1 reference

16 May 2018

1 reference

1

1 reference

16 May 2018

author name string

Jason Rice

series ordinal

2

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

16 May 2018

European Journal of Immunology

published in

1 reference

16 May 2018

volume

36

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

1070-1073

1 reference

16 May 2018

DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

Critical Components of a DNA Fusion Vaccine Able to Induce Protective Cytotoxic T Cells Against a Single Epitope of a Tumor Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

B cell activation, tolerance and antigen-presenting function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Enhancement of DNA vaccine potency in rhesus macaques by electroporation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

DNA vaccines to attack cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636085

7 January 2021

Identifiers

DOI

10.1002/EJI.200636085

1 reference

16 May 2018

1 reference

16 May 2018